Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Oncternal Therapeutics, Inc.Listing unverified | AwardD (derivative) | $92.8K | SEC | ||
Oncternal Therapeutics, Inc.Listing unverified | Buy | $54.3K | conv 86ClusterFirst in 12mo | SEC | |
Oncternal Therapeutics, Inc.Listing unverified | Buy | $54.3K | conv 91ClusterFirst in 12mo | SEC | |
Oncternal Therapeutics, Inc.Listing unverified | AwardD (derivative) | $147K | SEC | ||
Oncternal Therapeutics, Inc.Listing unverified | Buy | $8.2K | conv 78ClusterFirst in 12mo | SEC | |
Oncternal Therapeutics, Inc.Listing unverified | AwardD (derivative) | $421K | SEC | ||
Oncternal Therapeutics, Inc.Listing unverified | AwardD (derivative) | $358.8K | SEC | ||
Oncternal Therapeutics, Inc.Listing unverified | Sell | $22.2K | SEC | ||
Oncternal Therapeutics, Inc.Listing unverified | AwardD (derivative) | $267.6K | SEC | ||
Oncternal Therapeutics, Inc.Listing unverified | AwardD (derivative) | $113.4K | SEC |